Compare FATE & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FATE | GORO |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.5M | 112.3M |
| IPO Year | 2013 | N/A |
| Metric | FATE | GORO |
|---|---|---|
| Price | $1.06 | $0.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $3.92 | $1.38 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,137,000.00 | ★ $61,430,000.00 |
| Revenue This Year | N/A | $8.76 |
| Revenue Next Year | N/A | $85.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $0.16 |
| 52 Week High | $2.02 | $1.18 |
| Indicator | FATE | GORO |
|---|---|---|
| Relative Strength Index (RSI) | 46.03 | 61.43 |
| Support Level | $1.03 | $0.82 |
| Resistance Level | $1.19 | $0.89 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 36.71 | 83.78 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.